Articles tagged as "HIV This Month 2017 #02 - February 2017"

Welcome to UNAIDS Science now and to the second issue of HIV this month in 2017! 

The annual Conference on Retroviruses and Opportunistic Infections (CROI) 2017 happened in Seattle, USA from February 13 to February 16, 2017. Among the presentations was the release of results from the phase III SWORD 1 and SWORD 2 studies which analyzed the efficacy, safety and tolerability of switching to dolutegravir + rilpivirine, and found that this single pill combination is as effective as a three to four drug regimen for those who have already reached viral suppression; and the Rakai study that found a 42% reduction in HIV incidence due to combination HIV prevention.  

A UNAIDS-WHO CROI 2017 update for staff is scheduled in the coming days and we'll be sure to send you an online invite.

On combination HIV prevention, don't miss the medical male circumcision articles also featured in this edition.


Peter Godfrey-Faussett and Celeste Sandoval


HIV This Month - February 2017

HIV this month. Issue no. 2. February 2017

Welcome to HIV this month!  In this issue, we cover the following topics:

HIV testing and treatment

Combination prevention

Key populations

Elimination of gender inequalities

Elimination of stigma

Health systems and services

To find out how you can access a majority of scientific journals free of charge, check the UNAIDS Science now website by clicking here. If you would like to subscribe to HIV this month issues, click here. Please let us know what your interests are and what you think of HIV this month by sending us an email here. If you would like to recommend an article for inclusion, please contact us. Remember, a wealth of information on the HIV epidemic and responses to it are accessible at

For full PDF access to this issue:
  • share

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Enter the characters shown in the image.